Phase 4 Chronic Heart Failure Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Vericiguat and Reverse Remodeling Indices in Heart Failure
Heart Failure With Reduced Ejection Fraction (HFrEF)Chronic Heart Failure
University Medical Centre Ljubljana60 enrolled1 locationNCT07405944
Recruiting
Phase 4
The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
Chronic Heart FailureIron Deficiency, Latent
Tomsk National Research Medical Center of the Russian Academy of Sciences100 enrolled1 locationNCT05793996
Recruiting
Phase 4
Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure
Iron-deficiencyChronic Heart FailureLeft Ventricular Systolic Dysfunction
Raffaele De Caterina60 enrolled1 locationNCT06270498
Recruiting
Phase 4
Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II
Chronic Heart Failure
Fazaia Ruth Pfau Medical College156 enrolled1 locationNCT06706791
Recruiting
Phase 4
Acetazolamide Per os for Decompensation of Heart Failure
Chronic Heart Failure
Samara State Medical University400 enrolled1 locationNCT05802849
Completed
Phase 4
Ultrarapid iron polymaltose infusion for treatment of iron deficiency anaemia in a general hospital population at a single centre safety study
Iron deficiency anaemiaAnaemia of chronic heart failureAnaemia of chronic kidney disease
Iouri Banakh300 enrolled1 locationACTRN12619000272190